You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematologic neoplasms

Showing 1 - 25 of 3,797
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Tumors Trial in Nanjing (virtual reality device)

Recruiting
  • Hematologic Neoplasms
  • virtual reality device
  • Nanjing, Jiangsu, China
    the First Affiliated Hospital of Nanjing Medical University
Oct 28, 2022

Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

Not yet recruiting
  • Hematologic Malignancy
  • +2 more
  • Flow Cytometry
  • Nanjing, Jiangsu, China
  • +2 more
Apr 17, 2023

Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial (Routine care as per

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +5 more
  • Routine care as per site standard.
  • (no location specified)
Sep 15, 2023

Hematologic Malignancy Trial (Cold-stored platelet concentrate)

Not yet recruiting
  • Hematologic Malignancy
  • Cold-stored platelet concentrate
  • (no location specified)
Apr 14, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

    Not yet recruiting
    • Hematopoietic Stem Cell Transplantation
    • Hematologic Malignancy
    • CliniMACS®
    • (no location specified)
    Oct 17, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Hefei, Anhui, China
      The First Affiliated Hospital of University of Science and Techn
    Jun 5, 2023

    Relmacabtagene Autoleucel in Hematologic Malignancies

    Not yet recruiting
    • Lymphoma, B-Cell
    • +2 more
    • Relmacabtagene Autoleucel
    • Beijing, Beijing, China
    • +1 more
    Nov 15, 2023

    Hematologic Cancer Trial (anxiety questionnaire)

    Not yet recruiting
    • Hematologic Cancer
    • anxiety questionnaire
    • (no location specified)
    Jul 11, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Xuzhou, Jiangsu, China
      Affiliated hospital of Xuzhou medical college
    Jun 7, 2023

    Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Sep 5, 2023

    Hematologic Malignancies Trial in Zhengzhou (RD13-02 cell infusion)

    Recruiting
    • Hematologic Malignancies
    • RD13-02 cell infusion
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jun 26, 2023

    Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

    Not yet recruiting
    • Hematologic Neoplasms
    • +5 more
    • umbilical cord derived mesenchymal stem cells
    • Wuhan, Hubei, China
    • +2 more
    Jan 3, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Jun 8, 2023

    Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

    Suspended
    • Hematologic Neoplasms
    • donor lymphocyte infusion
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 30, 2022

    SARS-CoV-2 Infection in Hematologic Tumors

    Active, not recruiting
    • SARS-CoV-2 Infection
    • Hematologic Malignancy
    • None intervention
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 13, 2023

    Hematologic Malignancy Trial in Tianjin (IMM01)

    Terminated
    • Hematologic Malignancy
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Sciences and Peking Union Medical Col
    May 5, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Hangzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 6, 2023

    Tissue Specimens From Solid Tumors or Blood Disorders and Their

    Recruiting
    • Neoplasms
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Hematologic Malignancy Trial in Bologna

      Recruiting
      • Hematologic Malignancy
        • Bologna, Italy
          Programma Dipartimentale Terapie Cellulari Avanzate
        Apr 17, 2023

        Hematologic Malignancy Trial (Cyclophosphamid, ATG)

        Not yet recruiting
        • Hematologic Malignancy
        • (no location specified)
        Oct 29, 2023

        Hematologic Malignancy Trial in Boston (Home Transfusion Program Components)

        Not yet recruiting
        • Hematologic Malignancy
        • Home Transfusion Program Components
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Aug 18, 2022

        Thoracic Scanographic Characteristics of Hematologic Malignancy

        Recruiting
        • Mediastinal Diseases
        • analysis of thoracic scans
        • Toulouse, France
          Muriel Picard
        Jan 12, 2023

        Cognitive Impairment, Hematologic Malignancy Trial in Birmingham (Modified ketogenic diet using an exogenous ketogenic formula,

        Recruiting
        • Cognitive Impairment
        • Hematologic Malignancy
        • Modified ketogenic diet using an exogenous ketogenic formula
        • Online cognitive training
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Jan 31, 2023

        Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

        Recruiting
        • Hematologic Malignancy
        • +4 more
        • Palliative Care
        • Usual Care
        • Boston, Massachusetts
          Massachusetts General Hospital Cancer Center
        Jan 24, 2023